| scholarly article | Q13442814 |
| P50 | author | Jörg Rahnenführer | Q1715479 |
| Agapios Sachinidis | Q90241000 | ||
| Marcel Leist | Q42136322 | ||
| Jan G Hengstler | Q49800573 | ||
| P2093 | author name string | Tancred Frickey | |
| Tanja Waldmann | |||
| Marianna Grinberg | |||
| Margit Henry | |||
| Giorgia Pallocca | |||
| P2860 | cites work | Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association | Q22253267 |
| Polychlorinated biphenyls disturb differentiation of normal human neural progenitor cells: clue for involvement of thyroid hormone receptors | Q24813568 | ||
| State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology | Q26852097 | ||
| Consensus report on the future of animal-free systemic toxicity testing | Q27008968 | ||
| Chemical Safety Assessment Using Read-Across: Assessing the Use of Novel Testing Methods to Strengthen the Evidence Base for Decision Making | Q28082423 | ||
| Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities | Q28388774 | ||
| Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts | Q28397001 | ||
| Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1 | Q28593256 | ||
| ToxPi GUI: an interactive visualization tool for transparent integration of data from diverse sources of evidence | Q30579674 | ||
| A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors | Q30662775 | ||
| The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function. | Q30806520 | ||
| Improved scoring of functional groups from gene expression data by decorrelating GO graph structure | Q31036410 | ||
| Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression | Q31139684 | ||
| Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate | Q33402014 | ||
| Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants. | Q50744606 | ||
| Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. | Q50790349 | ||
| The SEURAT-1 approach towards animal free human safety assessment. | Q51037430 | ||
| Use of high content image analysis to detect chemical-induced changes in synaptogenesis in vitro | Q51897355 | ||
| RefPlus: an R package extending the RMA Algorithm. | Q51910651 | ||
| Hazard assessment of methylmercury toxicity to neuronal induction in embryogenesis using human embryonic stem cells. | Q51942330 | ||
| In vitro teratogenic potential of two antifungal triazoles: triadimefon and triadimenol. | Q52170060 | ||
| The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. | Q53135035 | ||
| Temporal concordance between apical and transcriptional points of departure for chemical risk assessment. | Q53333222 | ||
| Polybrominated diphenyl ethers cause oxidative stress in human umbilical vein endothelial cells. | Q54457391 | ||
| Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals | Q57554886 | ||
| Guidance on good cell culture practice. a report of the second ECVAM task force on good cell culture practice | Q81253971 | ||
| Assessment of chemical-induced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures | Q83461859 | ||
| Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+) | Q33720121 | ||
| From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. | Q33794480 | ||
| Environmental impact on vascular development predicted by high-throughput screening | Q33970802 | ||
| Predictive models of prenatal developmental toxicity from ToxCast high-throughput screening data | Q34004475 | ||
| Use of aggregating brain cell cultures to study developmental effects of organophosphorus insecticides. | Q34055863 | ||
| Zebrafish developmental screening of the ToxCast™ Phase I chemical library. | Q34105781 | ||
| The GARD assay for assessment of chemical skin sensitizers | Q34432592 | ||
| Hirschsprung disease, associated syndromes and genetics: a review | Q34584242 | ||
| Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. | Q34649841 | ||
| Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes | Q34760242 | ||
| Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II. | Q34979500 | ||
| International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes | Q35024730 | ||
| Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery | Q35137761 | ||
| Involvement of endothelin receptors in normal and pathological development of neural crest cells | Q35190570 | ||
| Toxicogenomics directory of chemically exposed human hepatocytes | Q35423042 | ||
| Induction of the neural crest and the opportunities of life on the edge. | Q35909068 | ||
| Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism | Q35978121 | ||
| Evaluation of developmental toxicants and signaling pathways in a functional test based on the migration of human neural crest cells | Q36229064 | ||
| Metabolic depletion of ATP by fructose inversely controls CD95- and tumor necrosis factor receptor 1-mediated hepatic apoptosis | Q36404639 | ||
| Characterization of Conserved Toxicogenomic Responses in Chemically Exposed Hepatocytes across Species and Platforms. | Q36675500 | ||
| Comparative neurotoxicity screening in human iPSC-derived neural stem cells, neurons and astrocytes | Q37274325 | ||
| Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. | Q37444336 | ||
| Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. | Q37644135 | ||
| Compound selection for in vitro modeling of developmental neurotoxicity | Q38015145 | ||
| Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach | Q38319756 | ||
| Transcriptome-based functional classifiers for direct immunotoxicity | Q38481888 | ||
| Transcriptomic concentration-response evaluation of valproic acid, cyproconazole, and hexaconazole in the neural embryonic stem cell test (ESTn). | Q38500125 | ||
| Time-response evaluation by transcriptomics of methylmercury effects on neural differentiation of murine embryonic stem cells | Q38502163 | ||
| Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing | Q38504903 | ||
| Grouping of histone deacetylase inhibitors and other toxicants disturbing neural crest migration by transcriptional profiling | Q38846789 | ||
| A high throughput screening system for predicting chemically-induced reproductive organ deformities. | Q38926766 | ||
| Liprin-α1, ERC1 and LL5 define polarized and dynamic structures that are implicated in cell migration. | Q38979205 | ||
| Technical guide for applications of gene expression profiling in human health risk assessment of environmental chemicals. | Q39010475 | ||
| Genomic allergen rapid detection in-house validation--a proof of concept | Q39011099 | ||
| Read-across approaches--misconceptions, promises and challenges ahead | Q39103424 | ||
| Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods. | Q39247575 | ||
| Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals. | Q39594231 | ||
| Food for thought ... considerations and guidelines for basic test method descriptions in toxicology. | Q39793216 | ||
| The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants | Q39870835 | ||
| Cytotoxicity and gene expression profiling of two hydroxylated polybrominated diphenyl ethers in human H295R adrenocortical carcinoma cells. | Q39903702 | ||
| The dawning of a new age of toxicology. | Q40081577 | ||
| MPTP's pathway of toxicity indicates central role of transcription factor SP1. | Q40124758 | ||
| Development of a mechanistically-based genetically engineered PC12 cell system to detect p53-mediated cytotoxicity | Q40178134 | ||
| Genetic markers and animal models of neurocristopathy | Q40425551 | ||
| Use of alternative assays to identify and prioritize organophosphorus flame retardants for potential developmental and neurotoxicity. | Q40522904 | ||
| The ChemScreen project to design a pragmatic alternative approach to predict reproductive toxicity of chemicals | Q41471602 | ||
| ATP controls neuronal apoptosis triggered by microtubule breakdown or potassium deprivation | Q41942673 | ||
| From smoking guns to footprints: mining for critical events of toxicity pathways in transcriptome data | Q42641582 | ||
| Transcriptomic analysis in the developing zebrafish embryo after compound exposure: individual gene expression and pathway regulation. | Q42710654 | ||
| Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome | Q42717337 | ||
| Mechanistic validation. | Q42725423 | ||
| Early genetic control of craniofacial development is affected by the in vitro exposure of rat embryos to the fungicide triadimefon | Q42755913 | ||
| Integrative chemical-biological read-across approach for chemical hazard classification | Q42921015 | ||
| Cascade of caspase activation in potassium-deprived cerebellar granule neurons: targets for treatment with peptide and protein inhibitors of apoptosis | Q43581941 | ||
| MALAT-1 interacts with hnRNP C in cell cycle regulation | Q43908554 | ||
| Maturation-dependent neurotoxicity of lead acetate in vitro: implication of glial reactions | Q44141747 | ||
| Neural crest cell motility in valproic acid | Q44195081 | ||
| Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347. | Q45007557 | ||
| Integrated Testing Strategies (ITS) for safety assessment. | Q45955833 | ||
| Craniofacial and axial skeletal defects induced by the fungicide triadimefon in the mouse | Q46441198 | ||
| Use of within-array replicate spots for assessing differential expression in microarray experiments | Q48502901 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 1 | |
| P921 | main subject | transcriptome | Q252857 |
| biomarker | Q864574 | ||
| P304 | page(s) | 159-180 | |
| P577 | publication date | 2015-12-26 | |
| P1433 | published in | Archives of Toxicology | Q635837 |
| P1476 | title | Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration | |
| P478 | volume | 90 |
| Q36364780 | Combination of multiple neural crest migration assays to identify environmental toxicants from a proof-of-concept chemical library |
| Q38698182 | Embryonic stem cells and the next generation of developmental toxicity testing. |
| Q52656595 | Ensemble of rankers for efficient gene signature extraction in smoke exposure classification. |
| Q46756566 | Fibronectin is a stress responsive gene regulated by HSF1 in response to geldanamycin. |
| Q64965417 | Highlight report: Cell type selection for toxicity testing. |
| Q42933280 | Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk |
| Q30234405 | Human cost burden of exposure to endocrine disrupting chemicals. A critical review |
| Q38862416 | Impairment of human neural crest cell migration by prolonged exposure to interferon-beta. |
| Q38753758 | In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities |
| Q50421707 | Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity. |
| Q30835700 | Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use. |
| Q49978669 | Stem cells in toxicological research |
Search more.